New diabetes clinical trial: Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab
- Get link
- X
- Other Apps
Published on: October 22, 2020 at 09:30PM
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: Teplizumab; Other: Placebo
Sponsor: Provention Bio, Inc.
Enrolling by invitation
https://ift.tt/35pyBzc
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: Teplizumab; Other: Placebo
Sponsor: Provention Bio, Inc.
Enrolling by invitation
https://ift.tt/35pyBzc
Comments
Post a Comment